Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-12

Clinical Trial Update: 0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial of 0.075% capsaicin lotion evaluated for pain in peripheral diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0.075% capsaicin lotion (capsaicin)

Snippet

Sponsor: Thammasat University | Conditions: Peripheral Diabetic Neuropathy | Phase 3 | Status: COMPLETED